4//SEC Filing
Konidaris Tasos 4
Accession 0001628280-25-010713
CIK 0001723128other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:53 PM ET
Size
30.1 KB
Accession
0001628280-25-010713
Insider Transaction Report
Form 4
Konidaris Tasos
Executive Vice President & CFO
Transactions
- Exercise/Conversion
Class A Common Stock
2025-03-03+45,290→ 595,309 total - Tax Payment
Class A Common Stock
2025-03-03$8.76/sh−16,373$143,427→ 578,936 total - Exercise/Conversion
Class A Common Stock
2025-03-03+57,340→ 636,276 total - Exercise/Conversion
Class A Common Stock
2025-03-03+181,159→ 793,061 total - Exercise/Conversion
Class A Common Stock
2025-03-04+43,981→ 744,379 total - Tax Payment
Class A Common Stock
2025-03-04$8.84/sh−22,497$198,873→ 721,882 total - Exercise/Conversion
Restricted Stock Units
2025-03-03−45,290→ 45,290 total→ Class A Common Stock (45,290 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-03−57,340→ 114,679 total→ Class A Common Stock (57,340 underlying) - Award
Performance-Based Restricted Stock Units
2025-03-03+228,310→ 228,310 total→ Class A Common Stock (228,310 underlying) - Tax Payment
Class A Common Stock
2025-03-03$8.76/sh−24,374$213,516→ 611,902 total - Tax Payment
Class A Common Stock
2025-03-03$8.76/sh−92,663$811,728→ 700,398 total - Exercise/Conversion
Performance-Based Restricted Stock Units
2025-03-03−181,159→ 0 total→ Class A Common Stock (181,159 underlying) - Award
Restricted Stock Units
2025-03-03+114,155→ 114,154 total→ Class A Common Stock (114,155 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-04−43,981→ 131,945 total→ Class A Common Stock (43,981 underlying)
Footnotes (11)
- [F1]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
- [F10]The restricted stock units vest in four equal annual installments beginning on March 3, 2026.
- [F11]On March 4, 2024, the Reporting Person was granted 175,926 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F3]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
- [F4]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.
- [F5]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
- [F6]On March 3, 2022, the reporting person was granted 181,159 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- [F7]On March 3, 2023, the reporting person was granted 229,358 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- [F8]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F9]Represents a performance-based restricted stock unit grant of 114,155 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2028, the last day of the performance period.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001320982
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:53 PM ET
- Size
- 30.1 KB